Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age.
E. B. Walter,K. R. Talaat,C. Sabharwal,A. Gurtman,S. Lockhart,G. C. Paulsen,E. D. Barnett,F. M. Munoz,Y. Maldonado,B. A. Pahud,J. B. Domachowske,E. A. F. Simoes,U. N. Sarwar,N. Kitchin,L. Cunliffe,P. Rojo,E. Kuchar,M. Ramet,I Munjal,J. L. Perez,R. W. Frenck,E. Lagkadinou,K. A. Swanson,H. Ma,X. Xu,K. Koury,S. Mather,T. J. Belanger,D. Cooper,O. Tureci,P. R. Dormitzer,K. U. Jansen,W. C. Gruber New England Journal of Medicine（2021）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper